首页 > 最新文献

Archivos Peruanos de cardiologia y cirugia cardiovascular最新文献

英文 中文
[Radiofrequency catheter ablation in pediatric population: clinical, electrophysiological and therapeutic characteristics in a Peruvian pediatric hospital]. [儿科人群的射频导管消融:秘鲁一家儿科医院的临床、电生理和治疗特点]。
Pub Date : 2021-12-31 eCollection Date: 2021-10-01 DOI: 10.47487/apcyccv.v2i4.167
Luis Alfredo Melgar Quicaño, Fredy Chipa Ccasani

Objective: This study aims to describe the clinical, electrophysiological and therapeutic characteristics of pediatric patients with supraventricular tachycardia undergoing radiofrequency ablation.

Materials and methods: Observational, descriptive, retrospective study of children admitted for supraventricular tachycardia treatment at the Instituto Nacional de Salud del Niño during 2018 to 2021.

Results: Data from 62 procedures were collected, corresponding to 59 patients (mean age: 9.91 years, 61% male), 23% of procedures were performed in patients under 15kg, and two were in patients under 5kg. 63% of patients had a structurally normal heart, while 37% had some type of congenital heart disease, the most common being Ebstein's anomaly. The most widely used group of drugs were beta-blockers, mainly propranolol. Among the arrhythmias treated, 21.7% had preexcitation Syndrome, 33.3% had at least one hidden accessory pathway, 5% corresponded to permanent reciprocating junctional tachycardia, 5% intranodal tachycardia, 11.7% atrial tachycardia, 10 % atrial flutter, 5% had other types of tachycardia and in 5 cases no tachycardia was induced. Of the total procedures, 76% corresponded to electrophysiological study and ablation, four patients recurred.

Conclusions: The most common supraventricular tachycardia substrate in children was the presence of some accessory pathway. Radiofrequency catheter ablation could be applied in children with a high success rate and a low complication rate.

目的:本研究旨在描述儿童室上性心动过速射频消融术的临床、电生理和治疗特点。材料和方法:对2018年至2021年在国家厄尔尼诺研究所接受室上性心动过速治疗的儿童进行观察性、描述性、回顾性研究。结果:收集了62次手术的数据,对应于59名患者(平均年龄:9.91岁,61%为男性),23%的手术在15公斤以下的患者中进行,5kg以下患者2例。63%的患者心脏结构正常,37%的患者患有某种类型的先天性心脏病,最常见的是Ebstein畸形。最广泛使用的药物是β受体阻滞剂,主要是普萘洛尔。在接受治疗的心律失常中,21.7%患有预激综合征,33.3%至少有一个隐藏的旁道,5%对应于永久性的往复式交界性心动过速,5%的节内心动过速、11.7%的心房心动过速和10%的心房扑动,5%有其他类型的心动过速并且在5例中没有诱发心动过速。在全部手术中,76%对应于电生理研究和消融,4名患者复发。结论:儿童室上性心动过速最常见的基底是存在一些旁道。射频导管消融术可用于儿童,成功率高,并发症发生率低。
{"title":"[Radiofrequency catheter ablation in pediatric population: clinical, electrophysiological and therapeutic characteristics in a Peruvian pediatric hospital].","authors":"Luis Alfredo Melgar Quicaño,&nbsp;Fredy Chipa Ccasani","doi":"10.47487/apcyccv.v2i4.167","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i4.167","url":null,"abstract":"<p><strong>Objective: </strong>This study aims to describe the clinical, electrophysiological and therapeutic characteristics of pediatric patients with supraventricular tachycardia undergoing radiofrequency ablation.</p><p><strong>Materials and methods: </strong>Observational, descriptive, retrospective study of children admitted for supraventricular tachycardia treatment at the Instituto Nacional de Salud del Niño during 2018 to 2021.</p><p><strong>Results: </strong>Data from 62 procedures were collected, corresponding to 59 patients (mean age: 9.91 years, 61% male), 23% of procedures were performed in patients under 15kg, and two were in patients under 5kg. 63% of patients had a structurally normal heart, while 37% had some type of congenital heart disease, the most common being Ebstein's anomaly. The most widely used group of drugs were beta-blockers, mainly propranolol. Among the arrhythmias treated, 21.7% had preexcitation Syndrome, 33.3% had at least one hidden accessory pathway, 5% corresponded to permanent reciprocating junctional tachycardia, 5% intranodal tachycardia, 11.7% atrial tachycardia, 10 % atrial flutter, 5% had other types of tachycardia and in 5 cases no tachycardia was induced. Of the total procedures, 76% corresponded to electrophysiological study and ablation, four patients recurred.</p><p><strong>Conclusions: </strong>The most common supraventricular tachycardia substrate in children was the presence of some accessory pathway. Radiofrequency catheter ablation could be applied in children with a high success rate and a low complication rate.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 4","pages":"219-226"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/39/5e/apcyccv-2-219.PMC10506544.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41160925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Severe aortic stenosis and familial hypercholesterolemia]. [严重主动脉狭窄和家族性高胆固醇血症]。
Pub Date : 2021-12-31 eCollection Date: 2021-10-01 DOI: 10.47487/apcyccv.v2i4.166
Milagros Mallma Gomez, Josafat Condori Ccallo, David Miranda Noé

Homozygous familial hypercholesterolemia (HFH) is a rare and life-threatening disease that can manifest as coronary artery disease or severe aortic stenosis before twenties. We present the case of a male adolescent who was hospitalized with a clinical diagnosis of HFH and severe aortic stenosis. He underwent aortic valve replacement with mechanical prosthesis and aortic annulus enlargement, and two aortocoronary bypasses were implanted due to an intraoperative complication. The patient evolved favourably and was discharged with combination therapy with high-intensity statins and ezetimibe.

纯合子家族性高胆固醇血症(HFH)是一种罕见且危及生命的疾病,在20多岁之前可表现为冠状动脉疾病或严重主动脉狭窄。我们报告了一名男性青少年的病例,他因临床诊断为HFH和严重主动脉狭窄而住院。他接受了机械瓣膜置换术和主动脉环扩大术,并因术中并发症植入了两条主动脉-冠状动脉旁路。患者病情进展良好,通过高强度他汀类药物和依折麦布的联合治疗出院。
{"title":"[Severe aortic stenosis and familial hypercholesterolemia].","authors":"Milagros Mallma Gomez,&nbsp;Josafat Condori Ccallo,&nbsp;David Miranda Noé","doi":"10.47487/apcyccv.v2i4.166","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i4.166","url":null,"abstract":"<p><p>Homozygous familial hypercholesterolemia (HFH) is a rare and life-threatening disease that can manifest as coronary artery disease or severe aortic stenosis before twenties. We present the case of a male adolescent who was hospitalized with a clinical diagnosis of HFH and severe aortic stenosis. He underwent aortic valve replacement with mechanical prosthesis and aortic annulus enlargement, and two aortocoronary bypasses were implanted due to an intraoperative complication. The patient evolved favourably and was discharged with combination therapy with high-intensity statins and ezetimibe.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 4","pages":"268-273"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/94/c5/apcyccv-2-268.PMC10506555.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41107319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Comparative analysis of myocardial deformation in patients recovered from mild SARS-CoV-2 infection]. [轻度严重急性呼吸系统综合征冠状病毒2型感染康复患者心肌变形的比较分析]。
Pub Date : 2021-12-31 eCollection Date: 2021-10-01 DOI: 10.47487/apcyccv.v2i4.175
Roberto Baltodano-Arellano, Kelly Cupe-Chacalcaje, Paol Rojas, Giovanni Meneses, Dante Urdanivia-Ruiz, Eliana Rafael-Horna, Luis Falcón-Quispe, Ángela Cachicatari-Beltrán, Karla Sue América Hurtado-Belizario, Gerald Lévano-Pachas

Objectives: During acute infection by the SARS-CoV-2 virus, myocardial involvement has been demonstrated; it is unknown if cardiovascular sequelae in patients recovered from this infection and if these are associated with global morbidity and mortality. The objective of this study was to compare myocardial deformation in patients recovered from mild SARS-CoV-2 virus infection with healthy controls.

Materials and methods: This was a cross-sectional observational study that included 33 subjects recovered from mild SARS-CoV-2 infection, who were diagnosed in the previous three to six months, and 31 healthy volunteers, both groups free of cardiovascular risk factors. The study of myocardial deformation was performed using echocardiography with the speckle tracking modality. Clinical and anthropometric variables were compared.

Results: The 2D global longitudinal strain of the left ventricle was lower in the subjects recovered from mild SARS-CoV-2 infection than the controls (-20.2% ± 2.6 v -21.6% ± 2.4; p: 0.036). Both groups presented differences in the three ventricular levels, significant at the apical level (-21.2 ± 4.0 vs -23.4% ± 4.2; p: 0.044). The effect by levels shows an inverse Takotsubo pattern. The left ventricular ejection fraction was preserved in both groups (p: 0.153).

Conclusions: Left ventricular myocardial deformation is affected in subjects recovered from mild SARS-CoV-2 infection, while the ejection fraction was found in normal ranges. Our study shows a potential role of global longitudinal strain in the detection of subclinical myocardial alterations in patients who had SARS-CoV-2.

目的:在严重急性呼吸系统综合征冠状病毒2型病毒急性感染期间,心肌受累已得到证实;目前尚不清楚从这种感染中康复的患者的心血管后遗症是否与全球发病率和死亡率有关。本研究的目的是比较轻度严重急性呼吸系统综合征冠状病毒2型感染康复患者与健康对照组的心肌变形。材料和方法:这是一项横断面观察性研究,包括33名在前三到六个月内确诊的轻度严重急性呼吸系统综合征冠状病毒2型感染康复者和31名健康志愿者,这两组人都没有心血管风险因素。心肌变形的研究是使用超声心动图和斑点跟踪模式进行的。比较了临床和人体测量变量。结果:从轻度严重急性呼吸系统综合征冠状病毒2型感染中康复的受试者的左心室2D整体纵向应变低于对照组(-20.2%±2.6 v-21.6%±2.4;p:0.036)。两组在三个心室水平上都存在差异,在心尖水平上有显著性差异(-21.2±4.0 vs-23.4%±4.2;p:0.044)。各水平的影响显示出相反的Takotsubo模式。两组的左心室射血分数均保持不变(p:0.153)。结论:轻度严重急性呼吸系统综合征冠状病毒2型感染后康复的受试者左心室心肌变形受到影响,而射血分数在正常范围内。我们的研究表明,全局纵向应变在检测严重急性呼吸系统综合征冠状病毒2型患者亚临床心肌改变中的潜在作用。
{"title":"[Comparative analysis of myocardial deformation in patients recovered from mild SARS-CoV-2 infection].","authors":"Roberto Baltodano-Arellano,&nbsp;Kelly Cupe-Chacalcaje,&nbsp;Paol Rojas,&nbsp;Giovanni Meneses,&nbsp;Dante Urdanivia-Ruiz,&nbsp;Eliana Rafael-Horna,&nbsp;Luis Falcón-Quispe,&nbsp;Ángela Cachicatari-Beltrán,&nbsp;Karla Sue América Hurtado-Belizario,&nbsp;Gerald Lévano-Pachas","doi":"10.47487/apcyccv.v2i4.175","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i4.175","url":null,"abstract":"<p><strong>Objectives: </strong>During acute infection by the SARS-CoV-2 virus, myocardial involvement has been demonstrated; it is unknown if cardiovascular sequelae in patients recovered from this infection and if these are associated with global morbidity and mortality. The objective of this study was to compare myocardial deformation in patients recovered from mild SARS-CoV-2 virus infection with healthy controls.</p><p><strong>Materials and methods: </strong>This was a cross-sectional observational study that included 33 subjects recovered from mild SARS-CoV-2 infection, who were diagnosed in the previous three to six months, and 31 healthy volunteers, both groups free of cardiovascular risk factors. The study of myocardial deformation was performed using echocardiography with the speckle tracking modality. Clinical and anthropometric variables were compared.</p><p><strong>Results: </strong>The 2D global longitudinal strain of the left ventricle was lower in the subjects recovered from mild SARS-CoV-2 infection than the controls (-20.2% ± 2.6 v -21.6% ± 2.4; p: 0.036). Both groups presented differences in the three ventricular levels, significant at the apical level (-21.2 ± 4.0 vs -23.4% ± 4.2; p: 0.044). The effect by levels shows an inverse Takotsubo pattern. The left ventricular ejection fraction was preserved in both groups (p: 0.153).</p><p><strong>Conclusions: </strong>Left ventricular myocardial deformation is affected in subjects recovered from mild SARS-CoV-2 infection, while the ejection fraction was found in normal ranges. Our study shows a potential role of global longitudinal strain in the detection of subclinical myocardial alterations in patients who had SARS-CoV-2.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 4","pages":"227-232"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/80/apcyccv-2-227.PMC10506539.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41159081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ankle-brachial index: more than a diagnostic test? 踝臂指数:不仅仅是一种诊断测试?
Pub Date : 2021-12-31 eCollection Date: 2021-10-01 DOI: 10.47487/apcyccv.v2i4.168
Ludwig Cáceres-Farfán, Milagros Moreno-Loaiza, W Samir Cubas

The ankle-brachial index (ABI) is the relationship between the systolic blood pressure taken at the ankle level and the brachial artery. A pathological ABI (<0.90 or >1.40) indicates the presence of peripheral artery disease (PAD). Many studies indicate the great utility of this test in the diagnosis of PAD due to its ease of use, reproducibility, low cost, and high cost-effectiveness. This evaluation can be directly correlated with cardiovascular morbidity and mortality; however, it has recently been confirmed that a low ABI can be a predictor of major cardiovascular events, as it is related to diabetes mellitus, chronic coronary disease, stroke, and more. The objective of this work was to review the current evidence on the importance of ABI in the diagnosis of PAD and its main role as a predictor of cardiovascular morbidity and mortality.

踝臂指数(ABI)是在踝关节水平上测量的收缩压与肱动脉之间的关系。病理ABI(1.40)表明存在外周动脉疾病(PAD)。许多研究表明,由于该测试易于使用、可重复性、低成本和高成本效益,它在PAD诊断中具有很大的实用性。这种评估可以与心血管发病率和死亡率直接相关;然而,最近已经证实,低ABI可以预测重大心血管事件,因为它与糖尿病、慢性冠状动脉疾病、中风等有关。这项工作的目的是回顾ABI在PAD诊断中的重要性及其作为心血管发病率和死亡率预测指标的主要作用的现有证据。
{"title":"Ankle-brachial index: more than a diagnostic test?","authors":"Ludwig Cáceres-Farfán,&nbsp;Milagros Moreno-Loaiza,&nbsp;W Samir Cubas","doi":"10.47487/apcyccv.v2i4.168","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i4.168","url":null,"abstract":"<p><p>The ankle-brachial index (ABI) is the relationship between the systolic blood pressure taken at the ankle level and the brachial artery. A pathological ABI (<0.90 or >1.40) indicates the presence of peripheral artery disease (PAD). Many studies indicate the great utility of this test in the diagnosis of PAD due to its ease of use, reproducibility, low cost, and high cost-effectiveness. This evaluation can be directly correlated with cardiovascular morbidity and mortality; however, it has recently been confirmed that a low ABI can be a predictor of major cardiovascular events, as it is related to diabetes mellitus, chronic coronary disease, stroke, and more. The objective of this work was to review the current evidence on the importance of ABI in the diagnosis of PAD and its main role as a predictor of cardiovascular morbidity and mortality.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 4","pages":"254-262"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/7c/d4/apcyccv-2-254.PMC10506545.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41123173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Hypertrophic septal cardiomyopathy, the great simulator]. [肥厚性间隔心肌病,伟大的模拟器]。
Pub Date : 2021-12-31 eCollection Date: 2021-10-01 DOI: 10.47487/apcyccv.v2i4.171
Santiago Forero, Nelson Leandro Moreno

Hypertrophic cardiomyopathy is the more commonly (60 to 70 percent) genetically determined disease of the heart muscle caused by mutations in one of several sarcomere genes that encode components of the heart's contractile apparatus. It is characterized by disproportionate hypertrophy in the absence of a secondary cause. The clinical presentation is variable, ranging from asymptomatic to heart failure or sudden cardiac death. Hypertrophy and abnormal ventricular configuration can result in dynamic left ventricular outflow obstruction in most cases. The goal of therapeutic interventions is largely to reduce dynamic obstruction, with different therapeutic options encompassing risk stratification for sudden death, genetic screening, lifestyle modifications, and drugs. A case of hypertrophic septal cardiomyopathy, a fairly frequent and under-diagnosed entity, is discussed below.

肥厚型心肌病是一种更常见的(60%至70%)由基因决定的心肌疾病,由编码心脏收缩器成分的几个肌节基因之一的突变引起。其特征是在没有次要原因的情况下过度肥大。临床表现多种多样,从无症状到心力衰竭或心源性猝死。在大多数情况下,肥厚和心室结构异常可导致动态左心室流出道阻塞。治疗干预的目标主要是减少动态阻塞,不同的治疗选择包括猝死风险分层、基因筛查、生活方式改变和药物。肥厚性间隔型心肌病是一种常见且诊断不足的疾病,下面将对其进行讨论。
{"title":"[Hypertrophic septal cardiomyopathy, the great simulator].","authors":"Santiago Forero,&nbsp;Nelson Leandro Moreno","doi":"10.47487/apcyccv.v2i4.171","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i4.171","url":null,"abstract":"<p><p>Hypertrophic cardiomyopathy is the more commonly (60 to 70 percent) genetically determined disease of the heart muscle caused by mutations in one of several sarcomere genes that encode components of the heart's contractile apparatus. It is characterized by disproportionate hypertrophy in the absence of a secondary cause. The clinical presentation is variable, ranging from asymptomatic to heart failure or sudden cardiac death. Hypertrophy and abnormal ventricular configuration can result in dynamic left ventricular outflow obstruction in most cases. The goal of therapeutic interventions is largely to reduce dynamic obstruction, with different therapeutic options encompassing risk stratification for sudden death, genetic screening, lifestyle modifications, and drugs. A case of hypertrophic septal cardiomyopathy, a fairly frequent and under-diagnosed entity, is discussed below.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 4","pages":"274-278"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d4/71/apcyccv-2-274.PMC10506570.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41163107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Hypertonic saline solution and high dose of diuretic, ¿what do we know and how can we use them in persistent congestion?] [高渗盐水溶液和高剂量利尿剂,我们知道什么?我们如何在持续充血中使用它们?]
Pub Date : 2021-12-31 eCollection Date: 2021-10-01 DOI: 10.47487/apcyccv.v2i4.159
Juan D Orozco Burbano, Clara I Saldarriaga Giraldo, Diego A Echeverri Marín

The presence of decompensated heart failure continues to be a condition with high rates of hospitalization, impact on the health system, and quality of life for those who suffer it. The mainstay of treatment in these cases are diuretics. However, the resistance to this pharmacological group may occasionally occur, generating an inadequate negative fluid balance and persistence of congestion with negative clinical outcomes. Hypertonic saline solution with high doses of diuretic emerges as a therapeutic option for this group of patients with probable physiological, and clinical benefits on hospitalization and re-admission rates due to heart failure decompensation. A review of the most relevant aspects and benefits of this combination is discussed in this article.

失代偿性心力衰竭仍然是一种住院率高、对卫生系统和患者生活质量有影响的疾病。这些病例的主要治疗方法是利尿剂。然而,偶尔可能会出现对该药物组的耐药性,产生不充分的负液体平衡和持续的充血,并产生负面的临床结果。高剂量利尿剂的高渗盐水溶液是这组患者的一种治疗选择,可能对心力衰竭失代偿导致的住院率和再入院率有生理和临床益处。本文讨论了这种组合的最相关方面和好处。
{"title":"[Hypertonic saline solution and high dose of diuretic, ¿what do we know and how can we use them in persistent congestion?]","authors":"Juan D Orozco Burbano,&nbsp;Clara I Saldarriaga Giraldo,&nbsp;Diego A Echeverri Marín","doi":"10.47487/apcyccv.v2i4.159","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i4.159","url":null,"abstract":"<p><p>The presence of decompensated heart failure continues to be a condition with high rates of hospitalization, impact on the health system, and quality of life for those who suffer it. The mainstay of treatment in these cases are diuretics. However, the resistance to this pharmacological group may occasionally occur, generating an inadequate negative fluid balance and persistence of congestion with negative clinical outcomes. Hypertonic saline solution with high doses of diuretic emerges as a therapeutic option for this group of patients with probable physiological, and clinical benefits on hospitalization and re-admission rates due to heart failure decompensation. A review of the most relevant aspects and benefits of this combination is discussed in this article.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 4","pages":"247-253"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c0/c1/apcyccv-2-247.PMC10506575.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41124308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Ventricular diverticulum in Cantrell´s pentalogy: rare but not isolated entities]. [坎特雷尔五脏病学中的心室憩室:罕见但非孤立的实体]。
Pub Date : 2021-12-31 eCollection Date: 2021-10-01 DOI: 10.47487/apcyccv.v2i4.162
María Concepción Rocha-Arrieta, Antonio Arias-Díaz, Enrique Felipe Soto Zárate, Gabriel Elias Vergara Vergara, Guillermo José Aristizábal Villa, Gustavo Adolfo Brochet Bayona

Pentalogy of Cantrell is a rare entity characterized by a combination of alterations, among which the following stand out: defects of the pericardium, heart, diaphragm, lower third of sternum and abdominal wall. On the other hand, congenital cardiac diverticulum is a rare malformation whose presentation is associated with Cantrell's pentalogy in some cases. We present the case of a child with Cantrell's pentalogy who, during follow-up, was diagnosed with left ventricular diverticulum, which required surgical management with a favorable outcome. Addressing these conditions requires the use of cardiovascular images that allow timely decision-making by the treating team.

Cantrell五脏病学是一种罕见的疾病,其特征是多种改变,其中最突出的是:心包、心脏、横膈膜、胸骨下三分之一和腹壁的缺陷。另一方面,先天性心脏憩室是一种罕见的畸形,其表现在某些情况下与坎特雷尔五脏六腑有关。我们介绍了一个患有Cantrell五脏病学的儿童的病例,在随访期间,他被诊断为左心室憩室,需要手术治疗,结果良好。解决这些问题需要使用心血管图像,以便治疗团队及时做出决策。
{"title":"[Ventricular diverticulum in Cantrell´s pentalogy: rare but not isolated entities].","authors":"María Concepción Rocha-Arrieta,&nbsp;Antonio Arias-Díaz,&nbsp;Enrique Felipe Soto Zárate,&nbsp;Gabriel Elias Vergara Vergara,&nbsp;Guillermo José Aristizábal Villa,&nbsp;Gustavo Adolfo Brochet Bayona","doi":"10.47487/apcyccv.v2i4.162","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i4.162","url":null,"abstract":"<p><p>Pentalogy of Cantrell is a rare entity characterized by a combination of alterations, among which the following stand out: defects of the pericardium, heart, diaphragm, lower third of sternum and abdominal wall. On the other hand, congenital cardiac diverticulum is a rare malformation whose presentation is associated with Cantrell's pentalogy in some cases. We present the case of a child with Cantrell's pentalogy who, during follow-up, was diagnosed with left ventricular diverticulum, which required surgical management with a favorable outcome. Addressing these conditions requires the use of cardiovascular images that allow timely decision-making by the treating team.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 4","pages":"263-267"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/87/2b/apcyccv-2-263.PMC10506561.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41142048","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epidemiological characteristics of heart transplant recipients in Peru 2010-2020]. 【2010-2020年秘鲁心脏移植受者的流行病学特征】。
Pub Date : 2021-12-31 eCollection Date: 2021-10-01 DOI: 10.47487/apcyccv.v2i4.187
Gracia Del Carmen Polo Lecca, Franz Ronald Soplopuco Palacios, Walter Alberto Alarco León, Oscar Nelson Aguirre Zurita, Cristian Aguilar Carranza, Ruth Eneida Villarroel Villa, Tommy Leonel Prado Gómez, José Luis Tapia Leonardo, Miguel Ángel Lescano Alva, Víctor Justo Robles Velarde, Julio Alberto Morón Castro, Yulma Donayre Moquillaza, Teresa Colque Rojas, Luis Javier Palma Ortecho, David Germán Gálvez Caballero

Objective: To evaluate the epidemiological, clinical, surgical, pathological characteristics and outcomes in the follow-up of heart transplant recipients at the National Cardiovascular Institute during 2010-2020.

Material and methods: A retrospective descriptive study was performed by reviewing the medical records of patients undergoing heart transplantation at a national referral center, describing the clinical, surgical, laboratory, pathology characteristics and survival of patients up to 10 years of follow-up.

Results: Eighty-six patients were transplanted in 10 years, the median age was 41 years (RIQ 28-56), being predominantly male (66.3%). The three leading causes of indication for heart transplantation were: dilated cardiomyopathy (48.9%), ischemic heart disease (17.4%), and myocarditis (6.9%). Total ischemia time was 160 minutes (RIQ 129.7-233.5). Survival at one, five, and ten years was 84.8%, 73.6%, and 65.7% respectively. The main cause of death was non-cardiac: infectious (39.1%) and of unknown origin (26%).

Conclusions: The main etiology of heart failure in heart transplant recipients in Peru in recent years was nonischemic dilated cardiomyopathy. We observed that the survival rate was similar to that of international registries; however, the rate of mortality due to infectious causes and death of unknown origin is high, which poses a challenge in the management of post-transplant patients.

目的:评估2010-2020年美国国家心血管研究所心脏移植受者的流行病学、临床、外科、病理学特征和随访结果。材料和方法:通过回顾在国家转诊中心接受心脏移植的患者的病历,进行回顾性描述性研究,描述了患者的临床、外科、实验室、病理特征和长达10年的随访。结果:86名患者在10年内被移植,中位年龄为41岁(RIQ 28-56),主要是男性(66.3%)。心脏移植指征的三个主要原因是:扩张型心肌病(48.9%)、缺血性心脏病(17.4%),总缺血时间为160分钟(RIQ 129.7-233.5),1年、5年和10年生存率分别为84.8%、73.6%和65.7%。主要死因为非心脏性:传染性(39.1%)和不明原因(26%)。结论:近年来秘鲁心脏移植受者心力衰竭的主要病因是非缺血性扩张型心肌病。我们观察到,存活率与国际登记处的存活率相似;然而,由于感染原因和不明原因死亡的死亡率很高,这对移植后患者的管理提出了挑战。
{"title":"[Epidemiological characteristics of heart transplant recipients in Peru 2010-2020].","authors":"Gracia Del Carmen Polo Lecca,&nbsp;Franz Ronald Soplopuco Palacios,&nbsp;Walter Alberto Alarco León,&nbsp;Oscar Nelson Aguirre Zurita,&nbsp;Cristian Aguilar Carranza,&nbsp;Ruth Eneida Villarroel Villa,&nbsp;Tommy Leonel Prado Gómez,&nbsp;José Luis Tapia Leonardo,&nbsp;Miguel Ángel Lescano Alva,&nbsp;Víctor Justo Robles Velarde,&nbsp;Julio Alberto Morón Castro,&nbsp;Yulma Donayre Moquillaza,&nbsp;Teresa Colque Rojas,&nbsp;Luis Javier Palma Ortecho,&nbsp;David Germán Gálvez Caballero","doi":"10.47487/apcyccv.v2i4.187","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i4.187","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the epidemiological, clinical, surgical, pathological characteristics and outcomes in the follow-up of heart transplant recipients at the National Cardiovascular Institute during 2010-2020.</p><p><strong>Material and methods: </strong>A retrospective descriptive study was performed by reviewing the medical records of patients undergoing heart transplantation at a national referral center, describing the clinical, surgical, laboratory, pathology characteristics and survival of patients up to 10 years of follow-up.</p><p><strong>Results: </strong>Eighty-six patients were transplanted in 10 years, the median age was 41 years (RIQ 28-56), being predominantly male (66.3%). The three leading causes of indication for heart transplantation were: dilated cardiomyopathy (48.9%), ischemic heart disease (17.4%), and myocarditis (6.9%). Total ischemia time was 160 minutes (RIQ 129.7-233.5). Survival at one, five, and ten years was 84.8%, 73.6%, and 65.7% respectively. The main cause of death was non-cardiac: infectious (39.1%) and of unknown origin (26%).</p><p><strong>Conclusions: </strong>The main etiology of heart failure in heart transplant recipients in Peru in recent years was nonischemic dilated cardiomyopathy. We observed that the survival rate was similar to that of international registries; however, the rate of mortality due to infectious causes and death of unknown origin is high, which poses a challenge in the management of post-transplant patients.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 4","pages":"233-239"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c8/7e/apcyccv-2-233.PMC10506564.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41145634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Pulmonary arterial hypertension and renal impairment in patients from the National Institute of Cardiology Dr. Ignacio Chávez, Mexico]. [墨西哥国家心脏病研究所Ignacio Chávez博士的患者肺动脉高压和肾损伤]。
Pub Date : 2021-12-31 eCollection Date: 2021-10-01 DOI: 10.47487/apcyccv.v2i4.150
Franklyn Colón, Anthony Gutiérrez, Annette G García, Lorgis Jiménez, Diego E Arbaje, Nayeli Zayas

Objective: The objective of the study was to describe the clinical characteristics and the evolution of the severity of pulmonary arterial hypertension (PAH) and the degree of renal failure.

Material and methods: A retrospective observational study was carried out in which the physical and electronic medical records of 60 patients older than 18 years with a diagnosis of pulmonary arterial hypertension were analyzed.

Results: In our study, 11.4% of the severe PAH group worsened renal function at six months, and 13.6% of the participants worsened it at one year. In contrast, in the group with moderate PAH, 18.8% worsened at six months, and 12.5% worsened at one year. Also, the GFR at one year was 54.15 mL/min/1.73 m2 in the moderate PAH group and in the severe PAH group was 73.55 mL/min/1.73 m2.

Conclusion: The results of this research suggest that the deterioration of kidney function is related to the severity of pulmonary arterial hypertension.

目的:本研究旨在描述肺动脉高压(PAH)的临床特征、严重程度和肾功能衰竭程度的演变。材料和方法:进行了一项回顾性观察研究,分析了60名18岁以上诊断为肺动脉高压的患者的物理和电子病历。结果:在我们的研究中,11.4%的严重PAH组在6个月时肾功能恶化,13.6%的参与者在1年时肾功能加重。相反,在中度PAH组中,18.8%在6个月时恶化,12.5%在1年时恶化。此外,中度PAH组一年时的GFR为54.15 mL/min/1.73 m2,重度PAH组为73.55 mL/min/1.76 m2。结论:本研究结果表明,肾功能恶化与肺动脉高压的严重程度有关。
{"title":"[Pulmonary arterial hypertension and renal impairment in patients from the National Institute of Cardiology Dr. Ignacio Chávez, Mexico].","authors":"Franklyn Colón,&nbsp;Anthony Gutiérrez,&nbsp;Annette G García,&nbsp;Lorgis Jiménez,&nbsp;Diego E Arbaje,&nbsp;Nayeli Zayas","doi":"10.47487/apcyccv.v2i4.150","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i4.150","url":null,"abstract":"<p><strong>Objective: </strong>The objective of the study was to describe the clinical characteristics and the evolution of the severity of pulmonary arterial hypertension (PAH) and the degree of renal failure.</p><p><strong>Material and methods: </strong>A retrospective observational study was carried out in which the physical and electronic medical records of 60 patients older than 18 years with a diagnosis of pulmonary arterial hypertension were analyzed.</p><p><strong>Results: </strong>In our study, 11.4% of the severe PAH group worsened renal function at six months, and 13.6% of the participants worsened it at one year. In contrast, in the group with moderate PAH, 18.8% worsened at six months, and 12.5% worsened at one year. Also, the GFR at one year was 54.15 mL/min/1.73 m<sup>2</sup> in the moderate PAH group and in the severe PAH group was 73.55 mL/min/1.73 m<sup>2</sup>.</p><p><strong>Conclusion: </strong>The results of this research suggest that the deterioration of kidney function is related to the severity of pulmonary arterial hypertension.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 4","pages":"240-246"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/05/de/apcyccv-2-240.PMC10506565.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41177502","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Acute Stanford type A aortic dissection associated with aortic coarctation repaired by Tirone E. David & debranching techniques with combined axillar and femoral perfusion: a case report. Tirone E.David和去支技术结合腋窝和股骨灌注修复与主动脉缩窄相关的急性斯坦福A型主动脉夹层:一例报告。
Pub Date : 2021-09-30 eCollection Date: 2021-07-01 DOI: 10.47487/apcyccv.v2i3.154
Francisco Guerrero, Karla Bautista, Giuseppe Salas, Edmy Callalli, Josías C Ríos

We present the case of a 38-year-old male with a diagnosis of Stanford A aortic dissection and associated coarctation of the thoracic aorta. Acute dissection associated with coarctation of the aorta is a rare problem and difficult to manage surgically. Establishing a cardiopulmonary bypass (CPB) with adequate flows is the main objective of the procedure; optimal cannulation ensures the protection of cerebral and visceral organs. We successfully performed aortic valve re-implantation surgery (T. David Surgery), replacement of the ascending aorta and aortic arch, as well as debranching of the supra-aortic trunks. The cannulation technique was axillary and femoral to guarantee flows through the coarctation area.

我们报告一例38岁男性,诊断为Stanford a主动脉夹层和相关的胸主动脉缩窄。与主动脉缩窄相关的急性夹层是一个罕见的问题,很难通过手术治疗。建立具有足够流量的体外循环(CPB)是该程序的主要目标;最佳插管可确保对大脑和内脏器官的保护。我们成功地进行了主动脉瓣再植入手术(T.David surgery),置换了升主动脉和主动脉弓,并清除了主动脉上干的分支。插管技术是腋窝和股骨,以保证通过缩窄区的流量。
{"title":"Acute Stanford type A aortic dissection associated with aortic coarctation repaired by Tirone E. David & debranching techniques with combined axillar and femoral perfusion: a case report.","authors":"Francisco Guerrero,&nbsp;Karla Bautista,&nbsp;Giuseppe Salas,&nbsp;Edmy Callalli,&nbsp;Josías C Ríos","doi":"10.47487/apcyccv.v2i3.154","DOIUrl":"https://doi.org/10.47487/apcyccv.v2i3.154","url":null,"abstract":"<p><p>We present the case of a 38-year-old male with a diagnosis of Stanford A aortic dissection and associated coarctation of the thoracic aorta. Acute dissection associated with coarctation of the aorta is a rare problem and difficult to manage surgically. Establishing a cardiopulmonary bypass (CPB) with adequate flows is the main objective of the procedure; optimal cannulation ensures the protection of cerebral and visceral organs. We successfully performed aortic valve re-implantation surgery (T. David Surgery), replacement of the ascending aorta and aortic arch, as well as debranching of the supra-aortic trunks. The cannulation technique was axillary and femoral to guarantee flows through the coarctation area.</p>","PeriodicalId":72295,"journal":{"name":"Archivos Peruanos de cardiologia y cirugia cardiovascular","volume":"2 3","pages":"211-215"},"PeriodicalIF":0.0,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/28/20/apcyccv-2-211.PMC10506551.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41168711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archivos Peruanos de cardiologia y cirugia cardiovascular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1